Doyle Anthony 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Aug 12, 2020
Insider Transaction Report
Form 4
Doyle Anthony
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-08-11$4.08/sh+54,000$220,320→ 54,000 total
4 · BIOCRYST PHARMACEUTICALS INC · Filed Aug 12, 2020
Common Stock